Cargando…
A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials
BACKGROUND: Given the inherent challenges of conducting randomized phase III trials in older cancer patients, single-arm phase II trials which assess the feasibility of a treatment that has already been shown to be effective in a younger population may provide a compelling alternative. Such an appro...
Autores principales: | Cabarrou, Bastien, Leconte, Eve, Sfumato, Patrick, Boher, Jean-Marie, Filleron, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608934/ https://www.ncbi.nlm.nih.gov/pubmed/36289451 http://dx.doi.org/10.1186/s12874-022-01748-w |
Ejemplares similares
-
Comparison of Variable Selection Methods for Time-to-Event Data in High-Dimensional Settings
por: Gilhodes, Julia, et al.
Publicado: (2020) -
An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011) -
Response adaptive designs for Phase II trials with binary endpoint based on context-dependent information measures()
por: Kasianova, Ksenia, et al.
Publicado: (2021) -
A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up
por: Belin, Lisa, et al.
Publicado: (2017) -
Endpoint surrogacy in oncology Phase 3 randomised controlled trials
por: Zhang, Jianrong, et al.
Publicado: (2020)